# 0409-9094-25 · Fentanyl Citrate Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker For 0409-9094-25 · Fentanyl Citrate Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-9094-25; generic name is Fentanyl Citrate Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-15. - **Package NDC:** 0409-9094-25 _(verified: appears in the quote below)_ - **Generic name:** Fentanyl Citrate Injection _(verified: appears in the quote below)_ - **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Available _(verified: appears in the quote below)_ - **Initial posting date:** 01/01/2012 _(verified: appears in the quote below)_ - **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 5357 _(our reading, not quoted from the source)_ - **Dosage form:** Injection _(verified: appears in its own passage below)_ - **Therapeutic category:** Analgesia/Addiction _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "01/01/2012", "package_ndc": "0409-9094-25", "generic_name": "Fentanyl Citrate Injection", "contact_info": "844-646-4398", "availability": "Available" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/24/2026", "therapeutic_category": [ "Analgesia/Addiction", "Pediatric" ], "dosage_form": "Injection", "presentation": "Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current" ### Status > "update_date": "08/24/2026", "therapeutic_category": [ "Analgesia/Addiction", "Pediatric" ], "dosage_form": "Injection", "presentation": "Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current" ### Last update date > "update_date": "08/24/2026", "therapeutic_category": [ "Analgesia/Addiction", "Pediatric" ], "dosage_form": "Injection", "presentation": "Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current" ### Dosage form > "update_date": "08/24/2026", "therapeutic_category": [ "Analgesia/Addiction", "Pediatric" ], "dosage_form": "Injection", "presentation": "Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current" ### Therapeutic category > "update_date": "08/24/2026", "therapeutic_category": [ "Analgesia/Addiction", "Pediatric" ], "dosage_form": "Injection", "presentation": "Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)", "company_name": "Hospira, Inc., a Pfizer Company", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-15. Review by: 2026-09-18. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).